title: Peritonitis due to Aspergillus nidulans and Its effective treatment with voriconazole: the first case report.
authors.forename: S
authors.initials: S
authors.lastname: Ulusoy
authors.forename: G
authors.initials: G
authors.lastname: Ozkan
authors.forename: I
authors.initials: I
authors.lastname: Tosun
authors.forename: K
authors.initials: K
authors.lastname: Kaynar
authors.forename: I
authors.initials: I
authors.lastname: Köksal
authors.forename: S
authors.initials: S
authors.lastname: Türkyilmaz
authors.forename: I
authors.initials: I
authors.lastname: Vetem
mesh_terms: D000328:Adult; D000935:Antifungal Agents / Q000008:administration & dosage / Q000627:therapeutic use; D001228:Aspergillosis / Q000175:diagnosis / Q000382:microbiology* / Q000628:therapy; D001233:Aspergillus nidulans / Q000302:isolation & purification*; D002408:Catheters, Indwelling / Q000009:adverse effects / Q000382:microbiology*; D020878:Device Removal; D003937:Diagnosis, Differential; D004305:Dose-Response Relationship, Drug; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007676:Kidney Failure, Chronic / Q000628:therapy*; D010535:Laparoscopy; D010531:Peritoneal Dialysis, Continuous Ambulatory / Q000009:adverse effects*; D010538:Peritonitis / Q000175:diagnosis / Q000382:microbiology* / Q000628:therapy; D011743:Pyrimidines / Q000008:administration & dosage / Q000627:therapeutic use*; D014230:Triazoles / Q000008:administration & dosage / Q000627:therapeutic use*; D065819:Voriconazole
chemical_list: D000935:Antifungal Agents; D011743:Pyrimidines; D014230:Triazoles; D065819:Voriconazole